Venture Capital

Updated:

Hangzhou Hegang Venture Capital

Jin Yufeng leads state-backed Hangzhou Hegang Venture Capital, a generalist VC investing from seed to growth and co-investing with Lilly Asia Ventures.

Hangzhou Hegang Venture Capital

Hangzhou Hegang Venture Capital is a Hangzhou-based investment company. It has invested in nine funds. Its regional focus is Asia.

General information

Firm type

Venture Capital

Location

Region

Asia

Country

China

City

Hangzhou

Corporate office

Hangzhou, Zhejiang, China

Principals

Jin Yufeng

Legal Representative

Sector focus

Healthcare ServicesEnterprise SoftwareAI/MLIndustrial TechFinTech

Frequently asked questions

Who controls Hangzhou Hegang Venture Capital?

The firm is majority-owned by the Hangzhou Qiantang New District Industrial Development Group, with ultimate control residing in the Qiantang New Area Management Committee, a government body overseeing the district. Jin Yufeng is the legal representative.

What is the Hangzhou New Track investment vehicle?

It is a partnership between Hangzhou Hegang Venture Capital and Tasly Biopharmaceutical Industry Group. The vehicle targets life sciences and biotech startups, aligning with Hangzhou's push to become a healthcare innovation hub.

Does Hegang co-invest with international firms?

Yes. Hegang has co-invested alongside Lilly Asia Ventures, notably in Lynk Pharmaceuticals.

What investment stages does the firm target?

Hegang invests from seed and startup rounds through to expansion and late-stage deals. It also makes fund-of-funds commitments.

How does Hegang source deals?

Deal flow is heavily influenced by the Qiantang New District's industrial policy. Startups seeking to locate in the district or align with Hangzhou's strategic sectors — such as biotech and advanced manufacturing — form the core pipeline.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Hangzhou Venture Capital profiles